Milk Recall Update As FDA Sets Risk Class Over Spoilage Fears
The recall was voluntarily initiated by the firm on December 13 last year and on January 17, the milk products were issued a ...
US FDA approves AstraZeneca's drug for breast cancer
The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of ...
FDA issues highest risk level recall for over 6,000 tubs of protein powder
Orgain has issued a Class I recall for its 30g Plant Protein Complete Protein Powder due to undeclared peanut allergens. The ...
Hosted on MSN1d
Why did the FDA issue a Class II risk for Horizon Organic Milk recall? Reasons explained
Milk brand Horizon Organic Dairy recalled one of its products on December 13, 2024, due to concerns about premature spoilage.
California Pizza Recall as FDA Issues Highest Risk Warning
What and soy are two of nine major allergens. Others are milk, eggs, sesame, fish, tree nuts, crustacean shellfish and ...
WebMD1h
FDA Approves New Treatment for Advanced Breast Cancer
The FDA has approved a new treatment for patients with a common form of breast cancer that has spread to other parts of the body or cannot be surgically removed.
Yogurt Recall Update As FDA Sets Risk Level Over Plastic Contamination
Greek yogurt has been recalled because it may contain foreign objects, given the FDA's second-most severe risk level.
This Biotech Stock Soared 116% in 2024, but Is It a Buy in 2025?
One of the hottest growth areas in the healthcare landscape these days is the obesity drug market because of a class of drugs ...
Plastic in Greek Yogurt? 16,000 cases of yogurt recalled in 3 states after FDA announcement
The U.S. FDA has issued a Class II recall for 15,834 cases of Wellsley Farm Vanilla Non-Fat Greek Yogurt due to possible ...
Can Lexapro Cause Weight Loss? What to Know
If you’ve been diagnosed with major depressive disorder or a form of anxiety, your mental health provider may prescribe the ...
Taiwan News5h
Recce Pharmaceuticals Doses All Patients in Phase II Trial of RECCE® 327 Topical Gel in Acute Bacterial Skin and Skin Structure Infections
Alan W. Dunton, MD, Chief Medical Advisor of Recce Pharmaceuticals, added, “We are thrilled to see such robust clinical results from our Phase II trial. These results demonstrate the potential of ...